AKT Ligands and Polynucleotides Encoding AKT Ligands
AssigneeIntrexon Corporation
InventorThomas D. REED
Life of this patent
Estimating the term…
Abstract
The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate AKT activity. The ligands, homopolyligands, and heteropolyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands, homopolyligands, and heteropolyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands, homopolyligands, and heteropolyligands.
Claims16
1-151. (canceled)
An isolated polynucleotide comprising a polynucleotide sequence encoding a polypeptide heteropolyligand comprising two or more polypeptides that are
- (a) at least 90% identical to SEQ ID NO:
- 90, 101, 102, 194, 195, 199, 200 and 204,
- (b) SEQ ID NO:
- 174, or
- (c) SEQ ID NO:
- 175,
- wherein Xaa is any amino acid.
Dependencies are inferred from the claim text.